|
EDSA Edesa Biotech Inc 1540159 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-5,407,611.00 |
| Balance Sheet |
|
Current Assets
|
$10,780,278.00 |
|
Assets
|
$12,721,195.00 |
|
Current Liabilities
|
$3,910,041.00 |
|
Liabilities
|
$1,832,827.00 |
|
Equity
|
$8,811,154.00 |
|
Shares Out
|
9633223.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-7,186,629.00 |
| Market Analysis |
Market Cap
|
$45,854,141.48 |
|
Price
|
$4.76 |
|
BVPS
|
0.91 |
|
PB
|
5.23 |
|
EPS
|
-0.60 |
|
FCF
|
$-7,186,629.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:53 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:44 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view EDSA documents filed with the SEC.
EDSA Filings
Clear
